FDAnews Drug Daily Bulletin

Mistral Pharma Acquires CuraMedica

May 8, 2007
A A

Mistral Pharma Inc. ("Mistral") announces the acquisition of CuraMedica (Canada) Inc. ("CuraMedica"). "Mistral is now an integrated pharmaceutical company" said Mr. Bertrand Bolduc, Mistral's President & CEO. "We now combine an exciting pipeline of branded controlled-release products and a soon to be approved product for the Canadian Market. We intend to use our pipeline of products for quid pro quo licensing deals in order to add new products to those coming from the CuraMedica acquisition" explained Mr. Bolduc.
CCN Matthews